Outcome of adding collagen matrix implant (Ologen) to Trabeculectomy–Trabeculotomy operation with MMC for primary congenital glaucoma
Sayed, K. (2017). Outcome of adding collagen matrix implant (Ologen) to Trabeculectomy–Trabeculotomy operation with MMC for primary congenital glaucoma. EKB Journal Management System, 21(2), 111-123. doi: 10.21608/smj.2017.41239
Khlooud Muhammad Sayed. "Outcome of adding collagen matrix implant (Ologen) to Trabeculectomy–Trabeculotomy operation with MMC for primary congenital glaucoma". EKB Journal Management System, 21, 2, 2017, 111-123. doi: 10.21608/smj.2017.41239
Sayed, K. (2017). 'Outcome of adding collagen matrix implant (Ologen) to Trabeculectomy–Trabeculotomy operation with MMC for primary congenital glaucoma', EKB Journal Management System, 21(2), pp. 111-123. doi: 10.21608/smj.2017.41239
Sayed, K. Outcome of adding collagen matrix implant (Ologen) to Trabeculectomy–Trabeculotomy operation with MMC for primary congenital glaucoma. EKB Journal Management System, 2017; 21(2): 111-123. doi: 10.21608/smj.2017.41239

Outcome of adding collagen matrix implant (Ologen) to Trabeculectomy–Trabeculotomy operation with MMC for primary congenital glaucoma

Sohag Medical Journal
Article 13, Volume 21, Issue 2, July 2017, Page 111-123  XML PDF (500.11 K)
Document Type: Original Article
DOI: 10.21608/smj.2017.41239
View on SCiNiTO View on SCiNiTO
Author
Khlooud Muhammad Sayed
Department of Ophthalmology Faculty of Medicine, Sohag University
Abstract
Purpose
To study the value of adding collagen matrix (CM) to the surgical procedure combined trabeculotomy-trabeculectomy with mitomycin C (CTTM) for the treatment of Primary congenital  glaucoma (PCG).
Patients and methods
Fourty eyes were operated upon. The CM was inserted under the scleral and conjunctival flaps. Follow up was for 6 -12months
Results
At 6 months; all eyes manifested full success. At 1 year; one eye manifested poor success. There were minimal complications in the form of intraoperative hyphema, vitreous loss and postoperative shallow anterior chamber, immunological reaction and thin avascular cystic blebs.
Conclusion
This study is novel in using both MMC and CM implant at the same time for augmentation of CTT procedure with highest success ever reported for PCG. Biodegradable CM markedly increased the short and long term surgical success with marked reduction of complications.
Supplementary Files
References
  1. Hamdi MM . Trabeculectomy assisted by collagen matrix implant (Ologen) in primary congenital glaucoma. J Egypt Ophthalmol Soc. 2013; 106:188–193.
  2. Cairns JE .Trabeculectomy. Preliminary report of a new method. Am J Ophthalmol. 1968; 66:673-679.
  3. Pescosolido N, Scarsella G & Risuleo G. An in vitro model for post-trabeculectomy: evaluation of drugs differently controlling cell proliferation. Acta Ophthalmol Scand Suppl. 2002;236: 259.
  4. Cillino S, Zeppa L, Di Pace F, Casuccio A, Morreale D, Bocchetta F & Lodato G. E-PTFE (Gore-Tex) implant with or without low dosage mitomycin-C as an adjuvant in penetrating glaucoma surgery: 2 year randomized clinical trial. Acta Ophthalmol. 2008; 86: 314–321.
  5. Boey PY, Narayanaswamy A, Zheng C, Perera SA, Htoon HM, Tun TA, Seah SK, Wong TT,  Aung T. Imaging of blebs after phacotrabeculectomy with Ologen collagen matrix implants Br J Ophthalmol.  2011; 95:340-344.
  6. Mandal AK, Chakrabarti D.  Update on congenital glaucoma. Indian J Ophthalmol. 2011; 59 Suppl:S148–S157.
  7. Sarkisian SR.  A replacement for antimetabolites? Ologen is a new product that modulates wound healing in glaucoma surgery. Glaucoma Today. 2010; 8:22–24.
  8. Hsu WC, Ritch R, Krupin T, et al. Tissue bioengineering for surgical bleb defects: an animal study. Graefes Arch Clin Exp Ophthalmol. 2008;246:709-717.
  9. Ritch R. Using bioengineered collagen matrix during trabeculectomy: biodegradable polymer implants show promise for improving the functioning of filtering blebs. Glaucoma Today. 2007;1:14–15.
  10. Mandal AK, Gothwal VK, Bagga H, Nutheti R, Mansoori T. Outcome of surgery on infants younger than 1 month with congenital glaucoma. Ophthalmology. 2003;  110:1909-1915.
  11. Reddy PK,  Dada T,  Sihota  R,  Panda  A, Khokkar SK; Gupta, V. Comparative Evaluation of Trabeculotomy- Trabeculectomy with Mitomycin C vs Trabeculectomy, with Mitomycin C for Primary Congenital Glaucoma Journal of Current Glaucoma Practice.2011; 5: 15-19.
  12. Christopher  J , Dickens H, Hoskins D.   Epidemiology and pathophysiology of congenital glaucoma. The Glaucomas. 1996;  2:729-738.
  13. Elder MJ. Combined trabeculotomy-trabeculectomy compared with primary trabeculectomy for congenital glaucoma. Br J Ophthalmol. 1994; 78: 745–748.
  14. Mandal AK, Naduvilath TJ, Jayagandan A. Surgical results of combined trabeculotomy-trabeculectomy for developmental glaucoma. Ophthalmology. 1998; 105: 974–982.
  15. Schwenn O, Pfeiffer N, Grehn F.  Trabeculotomy in congenital glaucoma. Graefes Arch Clin Exp Ophthalmol. 2000; 238:207-213.
  16. Yalvac IS, Satana B, Suveren A, Eksioglu U, Duman S. Success of trabeculotomy in patients with congenital glaucoma operated on within 3 months of birth. Eye. 2007;21:459-464.
  17. Essuman VA , Braimah IZ , Ndanu TA  and Ntim-Amponsa CT. Combined trabeculotomy and trabeculectomy: outcome for primary Congenital glaucoma in a West African population  Eye. 2007; 25: 77–83.
  18. Papaconstantinou D, Georgalas I, Karmiris E, Diagourtas A, Koutsandrea C, Ladas I, Apostolopoulos M, Georgopoulos G  Trabeculectomy with OloGen versus trabeculectomy for the treatment of glaucoma: a pilot study. Acta Ophthalmol. 2010; 88:80-85.
  19. Agarwal HC,  Sood NN, Sihota R, Sanga L, Honavar SG.  Mitomycin-C in Congenital Glaucoma Ophthalmic Surgery, Lasers and Imaging Retina. 1997; 12: 979-985.
  20. Zhang X, Du S, Fan Q, Peng S, Yu M, Ge J. Long-term surgical outcomes of primary congenital glaucoma in China. Clinics. 2009; 64:543-551.
  21. Bayoumi NHL.  Deep sclerectomy in pediatric glaucoma filtering surgery Eye. 2012;  26:1548–1553 .
Statistics
Article View: 172
PDF Download: 254